Clinical Trial Update: Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing short-course radiotherapy with CAPOX and tislelizumab versus long-course chemoradiation with tislelizumab for locally advanced rectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING